Trials / Completed
CompletedNCT01247337
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
Intra-hepatic Chemotherapy With Oxaliplatin Every Second Week in Combination With Systemic Gemcitabine and Capecitabine in Combination With Cetuximab in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma. A Phase II Trial.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Dorte Nielsen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic gemcitabine and capecitabine in combination with cetuximab in patient with non-resectable liver metastases from cholangiocarcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin, capecitabine, gemcitabine, cetuximab | Intrahepatic oxaliplatin |
| DRUG | Oxaliplatin, capecitabine, gemcitabine cetuximab | Oxaliplatin given intravenous |
Timeline
- Start date
- 2011-02-02
- Primary completion
- 2016-02-18
- Completion
- 2016-02-18
- First posted
- 2010-11-24
- Last updated
- 2020-10-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01247337. Inclusion in this directory is not an endorsement.